Nordhealth As · OSL:NORDH
Nordhealth As — Q1 2022 Earnings Presentation
23 slides from Nordhealth As's earnings presentation, 2022
Slide 1: Q1 2022 Presentation
(X] nordhealth Q12022 Presentation
Slide 2: Today's presenters
Today’s presenters Charles MacBain Mari Orttenvuori CEO CFO
Slide 3: Company updates
(X) nordhealth fo fo Company updates Charles MacBain, CEO
Slide 4: Our mission
Our mission Improve the daily lives of healthcare professionals
Slide 5: Leading Nordic healthcare SaaS company expanding internationally
Leading Nordic healthcare SaaS company expanding internationallyw 2022 business overview * We build & acquire practice management software (PMS) in select healthcare niches. Currently, our software solutions target veterinary, physiotherapy, psychotherapy, occupational and speech therapy clinics. Ve
Slide 6: Growth strategy
Growth strategy Medium term North Star: ARR per share 1. 2. 3. Hire, develop and empower A players and build great teams that can help us scale to a €110M+ ARR business Decentralized organization. Only HR, Finance and capital allocation is centralized. Focus on attractive healthcare niches. Currentl
Slide 7: Acquisition history
Acquisition history IN Several acquisitions completed since 2005 PROVET navisec trofast Sanimalis Acquired Praktiikka ribs > Entering the Acquired Sanimalis Acquired Provet Pet therapy segment Acquired Navicre Acquired Trofast and Vetserve NOVASOFT QB vet YOMA EasyPractice < CONSULTING i Easy| wv ve
Slide 8: Vetera acquisition
“J vetera About Leading Veterinary PMS serving more than 2,000 veterinary practices, clinics, and partners throughout Germany, Austria, and Switzerland. Founded in 1989 and headquartered in Eltville am Rhein, Germany 30 employees Customers include AniCura, IVC Evidensia and 6 out of 8 vet universiti
Slide 9: Q1 2022 KPIs
Q12022 KPIs —> 116% total 24% organic +8% organic 116% organic ARR growth ARR growth new customer net retention rate LTM ARR Q12022 LTM ARR Q12022 recruitments LTM ARR Q12022 LTM ARR Q1 2022 (= fam O20 ti ) S ($)) RY O-O EUR 27.5M EUR 0.34 1.9% organic Signed ARR ARR per share ARR gross churn Q12022
Slide 10: 116% YoY ARR growth
116% YoY ARR growth IN) 12.7 P.O] Q12021 ARR New signed ARR Net upsell ARR Churn Q12022 ARR Acquisitions Acquisitions Q12022 ARR excl. organic incl. acquisitions growth acquisitions 10
Slide 11: 14% QoQ ARR growth
14% QoQ ARR growth EURm 0.2 25.6 24.0 Q4 2021 ARR New Net upsell Churn Q12022 ARR signed ARR excl. ARR acquisitions 1.9 Acquisitions Qt 2022 ARR incl. Acquisitions Strong ARR growth across both Veterinary and Therapy business units at 14.4% Q?’22 organic signed ARR growth 7% Price increases only for
Slide 12: Q1 2022 Update
Q12022 Update New customers Product Updates * Contracting for pilot Provet Cloud at one of the 6 largest UK + Began development and presales of new pet parent mobile app. Beta Veterinary corporate chains. release Q3 2022. * Signed Terveystalo Healthcare Rehabilitation Clinics in Finland * Design Sys
Slide 13: Financial updates
(X) nordhealth GCEOLIAO Financial updates Mari Orttenvuori, CFO
Slide 14: Strong revenue growth in Q1 2022 vs. Q1 2021
Strong revenue growth in Q1 2022 vs. Q12021 Reported financials (EURm) 3.3 30 0.8 ari Qr22 AA mw Revenue Recurring revenue EBITDA Q1’22 revenue EUR 7.1M, up 111% YoY Q?’22 recurring revenue EUR 6.5M, up 117% YoY Q1'22 EBITDA EUR -1.1M Continue to be highly profitable in established markets, while re
Slide 15: Profit & Loss Statement
Profit & Loss Statement Recurring revenue 18.464 Other revenue 603 1836 Total revenues: ‘7056 20300 Other operating income 4 a 3 * Recurring revenues Q1'22 EUR 6.5M Total operating income 7060 3360 20331 Material and service: {1083} (408) (3662) - 91% of total revenues Personnel expenses (4.608) (15
Slide 16: Balance Sheet
Balance Sheet Consolidated Balance Sheet Unaudited Unaudited Audited 31 Mar 2021 31 Dec 2021 Intangible assets 5170 2625 4558 Cash and Cash Equivalents Deferred tax assets 46 - 45 Other cepitalized long-term expenses 0 30 68 * EUR 57.8M of cash and cash equivalents Goodwill 58.006 44 43.002 at the e
Slide 17: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement • • •
Slide 18: 2022 Financial calendar
2022 Financial calendar 2022 Half-yearly report on19 August 2022 fo fo 8
Slide 19: Forecasting 20-25% organic growth in 2022, excluding acquisitions
Forecasting 20-25% organic growth in 2022, excluding acquisitions ARR Forecast Outlook and final remarks EUR in millions Low High YE 2021 ARR 24.0 24.0 Organic Growth (excl. 2022 acquisitions) 48 6.0 EasyPractice 22 24 Vetera 15 17 Other acquisitions - - YE 2022 ARR 325 344 Reiterating our forecast
Slide 20: Q&A
Slide 21: nordhealth
(X] nordhealth
Slide 22: Appendix
Appendix Qu Foo oo
Slide 23: Our products
Our products IN) Electronic Health . . . Occupational and Speech , Record Software Veterinary Physiotherapists therapists Psychotherapists World Leading position Leaders in Norway and Finland, aiming to expand Practice Management AgeiitimeniCehandtav Unified Communication Inventory management Invoic